86 related articles for article (PubMed ID: 1702751)
21. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
Green-Johnson JM; Szewczuk MR
Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
[TBL] [Abstract][Full Text] [Related]
22. Evidence for an association of CD45 with 32,000-33,000 MW phosphoproteins on murine T and B lymphocytes.
Altin JG; Pagler EB; Parish CR
Immunology; 1994 Nov; 83(3):420-9. PubMed ID: 7835967
[TBL] [Abstract][Full Text] [Related]
23. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
24. A novel glycoprotein expressed on sheep T and B lymphocytes is involved in a T cell activation pathway.
Hein WR; McClure S; Beya MF; Dudler L; Trnka Z
J Immunol; 1988 May; 140(9):2869-75. PubMed ID: 2834446
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a CD3-like rat T cell surface antigen recognized by a monoclonal antibody.
Tanaka T; Masuko T; Yagita H; Tamura T; Hashimoto Y
J Immunol; 1989 Apr; 142(8):2791-5. PubMed ID: 2467940
[TBL] [Abstract][Full Text] [Related]
26. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
27. Studies on the monocyte dependence of T-cell proliferation induced by monoclonal antibodies directed against regions I and II of the CD2 antigen.
van Lier R; Bloemena E; Brouwer M; Van Heijst J; Weinreich S; Aarden L
Immunology; 1989 Jul; 67(3):333-8. PubMed ID: 2474490
[TBL] [Abstract][Full Text] [Related]
28. The "erythrocyte receptor" of T-lymphocytes and T11 target structure (T11TS): complementary cell interaction molecules involved in T-cell activation.
Hünig T; Tiefenthaler G; Mitnacht R; Köhler C; Lottspeich F; Meuer S
Behring Inst Mitt; 1987 Jun; (81):31-40. PubMed ID: 2888455
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
Dialynas DP; Quan ZS; Wall KA; Pierres A; Quintáns J; Loken MR; Pierres M; Fitch FW
J Immunol; 1983 Nov; 131(5):2445-51. PubMed ID: 6415170
[TBL] [Abstract][Full Text] [Related]
30. An anti-CD2 monoclonal antibody that both inhibits and stimulates T cell activation recognizes a subregion of CD2 distinct from known ligand-binding sites.
Kozarsky KF; Tsai C; Bott CM; Allada G; Li LL; Fox DA
Cell Immunol; 1993 Sep; 150(2):235-46. PubMed ID: 8103706
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel T cell surface disulfide-bonded dimer distinct from the alpha/beta antigen receptor.
Nagasawa R; Gross J; Kanagawa O; Townsend K; Lanier LL; Chiller J; Allison JP
J Immunol; 1987 Feb; 138(3):815-24. PubMed ID: 2433330
[TBL] [Abstract][Full Text] [Related]
32. Human T cell responses to IL-1 and IL-6 are dependent on signals mediated through CD2.
Endler-Jobst B; Schraven B; Hutmacher B; Meuer SC
J Immunol; 1991 Mar; 146(6):1736-42. PubMed ID: 1706379
[TBL] [Abstract][Full Text] [Related]
33. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
Hara T; Jung LK; Fu SM
J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
[TBL] [Abstract][Full Text] [Related]
34. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
[TBL] [Abstract][Full Text] [Related]
35. RPA-2.10: an anti-CD2 monoclonal antibody that inhibits alloimmune responses and monitors T cell activation.
Aversa GG; Bishop GA; Suranyi MG; Hall BM
Transplant Proc; 1987 Feb; 19(1 Pt 1):277-8. PubMed ID: 2908548
[No Abstract] [Full Text] [Related]
36. Analysis of CD4 and CD2 receptor function.
Goldman SJ; Bierer BE; Burakoff SJ
Princess Takamatsu Symp; 1988; 19():149-60. PubMed ID: 2908352
[TBL] [Abstract][Full Text] [Related]
37. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule.
Gerli R; Agea E; Muscat C; Ercolani R; Bistoni O; Tognellini R; Mariggió MA; Spinozzi F; Bertotto A
Cell Immunol; 1994 Apr; 155(1):205-18. PubMed ID: 7909498
[TBL] [Abstract][Full Text] [Related]
38. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
39. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
Ceuppens JL; Baroja ML
J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
